GEISTWERT Rechtsanwälte Lawyers Avvocati

https-www.unifiedpatentcourt.org-en-node-182730-ca67d0c09729

SANOFI-AVENTIS DEUTSCHLAND GMBH, SANOFI-AVENTIS GROUPE S.A., SANOFI WINTHROP INDUSTRIE S.A., and Regeneron Pharmaceuticals Inc. v. AMGEN, INC

Datum
2026-02-18
Kammer
Luxembourg (LU)
Verfahrensart
Generic application
Sprache
EN

Metadaten

Fall-IDhttps-www.unifiedpatentcourt.org-en-node-182730-ca67d0c09729
Aktenzeichen
Registerzeichen
Entscheidungsreferenz
Schlagwörter
Leitsätze

Dokumente und Volltext

Textextraktion: pypdf | Seiten: 5

1 ORDER of the Court of Appeal of the Unified Patent Court issued on 18 February 2026 on an application for suspensive effect APPLICANTS (RESPONDENTS BEFORE THE COURT OF APPEAL AND CLAIMANTS BEFORE THE COURT OF FIRST INSTANCE) 1. SANOFI-AVENTIS DEUTSCHLAND GMBH, Brüningstrasse 50, 65926, Frankfurt am Main, Germany 2. SANOFI-AVENTIS GROUPE S.A., 82 Avenue Raspail, 94250 Gentilly, France 3. SANOFI WINTHROP INDUSTRIE S.A., 82 Avenue Raspail, 94250 Gentilly, France hereinafter: (”Sanofi”) represented by Daniel Wise, attorney-at-law, Carpmaels & Ransford, London, The United Kingdom and other representatives from that law firm and Regeneron Pharmaceuticals Inc., 777 Old Saw Mill River Road, Tarrytown, NY 10591, USA hereinafter: (”Regeneron”) represented by Niels Hölder, attorney -at-law, Carpmae ...